Liver fibrosis often progresses long before symptoms appear. Test your understanding of the physiologic changes that make noninvasive detection of fibrosis possible, and see how well you can connect liver...
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
Metabolic dysfunction–associated steatohepatitis is becoming increasingly common in patients with type 2 diabetes and other metabolic risk factors. Test your knowledge of the key diagnostic features,...
There are four types of acute hepatic porphyria, but one type is significantly more common than the others. Are you familiar with the most common type of acute hepatic porphyria? Take this pop quiz to test...
How often should computed tomography scanning or magnetic resonance imaging scanning be performed for future screenings of hepatocellular carcinoma when ultrasonography is suboptimal? Take the quick quiz...
In recent years, the obesity pandemic has contributed to an increase in prevalence of nonalcoholic fatty liver disease, though body mass index is only one risk factor. Do you know the estimated global...
Current guidelines suggest screening children with obesity for nonalcoholic fatty liver disease. Do you know at which age children should begin screening?
